| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
chromodomain helicase DNA binding protein 7 | 0.441 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2010 | 2011 | ||||||||
|
sclerostin | 0.474 | 0.808 | 0.87 |
|
disease | 0.110 | None | < 0.001 | 0 | 0 | 2019 | 2019 | ||||||||
|
tubulin beta 6 class V | 0.686 | 0.462 | 1.7E-04 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
gelsolin | 0.475 | 0.885 | 3.9E-11 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
receptor associated protein of the synapse | 0.593 | 0.731 | 1.5E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 18 member A3 | 0.608 | 0.654 | 0.45 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
peroxisomal biogenesis factor 5 | 0.561 | 0.731 | 5.6E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
peroxisomal biogenesis factor 2 | 0.582 | 0.654 | 2.6E-04 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
peroxisomal biogenesis factor 19 | 0.585 | 0.731 | 3.2E-04 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
REV3 like, DNA directed polymerase zeta catalytic subunit | 0.588 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 5 member 7 | 0.597 | 0.654 | 1.5E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
UPF3B regulator of nonsense mediated mRNA decay | 0.619 | 0.615 | 0.98 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SIX homeobox 1 | 0.496 | 0.692 | 0.65 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
myotubularin related protein 14 | 0.674 | 0.615 | 1.4E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
chromosome X open reading frame 56 | 0.705 | 0.385 | 0.95 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
sodium voltage-gated channel alpha subunit 4 | 0.554 | 0.731 | 1.3E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ryanodine receptor 1 | 0.489 | 0.808 | 1.6E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ribosomal protein S6 kinase A3 | 0.491 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
spectrin beta, non-erythrocytic 4 | 0.686 | 0.462 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
leiomodin 3 | 0.700 | 0.423 | 1.6E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
platelet derived growth factor subunit B | 0.488 | 0.846 | 0.77 |
|
disease | 0.100 | None | 0 | 0 |